Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.
Banerjee S, Ghosh J, Sen S, Guha R, Dhar R, Ghosh M, Datta S, Raychaudhury B, Naskar K, Haldar AK, et al. Infect Immun. 2009 Jun; 77(6):2330-42. Epub 2009 Mar 16.